Companies / BOC Sciences / Imgatuzumab
BOC Sciences

Imgatuzumab | BOC Sciences

Imgatuzumab is a humanized monoclonal antibody directed against EGFR. Imgatuzumab acts as an immunomodulator used in the research of cancer therapy.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.